Literature DB >> 21160888

Genetic predisposition to Helicobacter pylori-induced gastric precancerous conditions.

Asahi Hishida1, Keitaro Matsuo, Yasuyuki Goto, Nobuyuki Hamajima.   

Abstract

Gastric cancer is the most common malignancy of the gastrointestinal tract in East Asian populations and the second most frequent cause of cancer-related mortality in the world. While previous studies have investigated the genetic factors involved in gastric carcinogenesis, there still exist relatively few studies that have investigated the genetic traits associated with the risk of gastric precancerous conditions. In this paper we will review the biology and genetic polymorphisms involved in the genesis of gastric precancerous conditions reported to date and discuss the future prospects of this field of study. The associations of gastric precancerous conditions with polymorphisms in the cytotoxin-associated gene A-related genes (e.g. PTPN11 G/A at intron 3, rs2301756), those in the genes involved in host immunity against Helicobacter pylori (H. pylori) infection (e.g. TLR4 +3725G/C, rs11536889) or polymorphisms of the genes essential for the development/ differentiation of the gastric epithelial cells (e.g. RUNX3 T/A polymorphism at intron 3, rs760805) have been reported to date. Genetic epidemiological studies of the associations between H. pylori-induced gastric precancerous conditions and other gene polymorphisms in these pathways as well as polymorphisms of the genes involved in other pathways like oxidative DNA damage repair pathways would provide useful evidence for the individualized prevention of these H. pylori-induced gastric precancerous conditions.

Entities:  

Keywords:  Gastric cancer; Gastric precancerous conditions; Genetic predisposition to disease; Helicobacter pylori; Single nucleotide polymorphisms

Year:  2010        PMID: 21160888      PMCID: PMC2999673          DOI: 10.4251/wjgo.v2.i10.369

Source DB:  PubMed          Journal:  World J Gastrointest Oncol


  107 in total

Review 1.  The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling.

Authors:  Benjamin G Neel; Haihua Gu; Lily Pao
Journal:  Trends Biochem Sci       Date:  2003-06       Impact factor: 13.807

2.  OGG1, MYH and MTH1 gene variants identified in gastric cancer patients exhibiting both 8-hydroxy-2'-deoxyguanosine accumulation and low inflammatory cell infiltration in their gastric mucosa.

Authors:  Masanori Goto; Kazuya Shinmura; Hidetaka Yamada; Toshihiro Tsuneyoshi; Haruhiko Sugimura
Journal:  J Genet       Date:  2008-08       Impact factor: 1.166

3.  Grb2 is a key mediator of helicobacter pylori CagA protein activities.

Authors:  Hitomi Mimuro; Toshihiko Suzuki; Jiro Tanaka; Momoyo Asahi; Rainer Haas; Chihiro Sasakawa
Journal:  Mol Cell       Date:  2002-10       Impact factor: 17.970

4.  Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis.

Authors:  G D Eslick; L L Lim; J E Byles; H H Xia; N J Talley
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

5.  Identification and association of polymorphisms in the interleukin-13 gene with asthma and atopy in a Dutch population.

Authors:  T D Howard; P A Whittaker; A L Zaiman; G H Koppelman; J Xu; M T Hanley; D A Meyers; D S Postma; E R Bleecker
Journal:  Am J Respir Cell Mol Biol       Date:  2001-09       Impact factor: 6.914

Review 6.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

Review 7.  Helicobacter pylori and gastric carcinogenesis.

Authors:  Masanori Hatakeyama
Journal:  J Gastroenterol       Date:  2009-03-07       Impact factor: 7.527

8.  Synergistic effect of Helicobacter pylori virulence factors and interleukin-1 polymorphisms for the development of severe histological changes in the gastric mucosa.

Authors:  Roland Rad; Christian Prinz; Bruno Neu; Mathilde Neuhofer; Marco Zeitner; Petra Voland; Ingrid Becker; Wolfgang Schepp; Markus Gerhard
Journal:  J Infect Dis       Date:  2003-07-03       Impact factor: 5.226

Review 9.  Functional consequences of toll-like receptor 4 polymorphisms.

Authors:  Bart Ferwerda; Matthew Bb McCall; Karlijn Verheijen; Bart-Jan Kullberg; André Jam van der Ven; Jos Wm Van der Meer; Mihai G Netea
Journal:  Mol Med       Date:  2008 May-Jun       Impact factor: 6.354

10.  The effect of 5-year vitamin C supplementation on serum pepsinogen level and Helicobacter pylori infection.

Authors:  Shizuka Sasazuki; Satoshi Sasaki; Yoshitaka Tsubono; Shunji Okubo; Masato Hayashi; Tadao Kakizoe; Shoichiro Tsugane
Journal:  Cancer Sci       Date:  2003-04       Impact factor: 6.716

View more
  16 in total

1.  Expression of secreted phospholipase A2-Group IIA correlates with prognosis of gastric adenocarcinoma.

Authors:  Chengwei Zhang; Haipeng Yu; Haiyan Xu; Lanlan Yang
Journal:  Oncol Lett       Date:  2015-09-21       Impact factor: 2.967

Review 2.  Implementation of gastric cancer screening - the global experience.

Authors:  Mārcis Leja; Weicheng You; M Constanza Camargo; Hiroshi Saito
Journal:  Best Pract Res Clin Gastroenterol       Date:  2014-09-28       Impact factor: 3.043

Review 3.  Clinical practice: Helicobacter pylori infection in childhood.

Authors:  Deniz Ertem
Journal:  Eur J Pediatr       Date:  2012-09-27       Impact factor: 3.183

4.  Follow-up of intestinal metaplasia in the stomach: When, how and why.

Authors:  Angelo Zullo; Cesare Hassan; Adriana Romiti; Michela Giusto; Carmine Guerriero; Roberto Lorenzetti; Salvatore Ma Campo; Silverio Tomao
Journal:  World J Gastrointest Oncol       Date:  2012-03-15

5.  Association of specific haplotype of tumor necrosis factor-α and interleukin-1β polymorphisms with Helicobacter pylori infection and gastric carcinogenesis.

Authors:  Fatemeh Nezamzadeh; Mahboobeh Asadyun; Amir Anbiyaiee; Mansour Sedighi; Abed Zahedi Bialvaei; Younes Khalili; Hamed Ebrahimzadeh Leylabadlo; Aylin Esmailkhani
Journal:  Germs       Date:  2021-12-29

6.  Positive association between Toll-like receptor 4 gene +896A/G polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis.

Authors:  Tian-Hui Zou; Zhen-Hua Wang; Jing-Yuan Fang
Journal:  Tumour Biol       Date:  2013-04-17

7.  Meta-analysis of the association between PTPN11 G/A polymorphism at intron 3 with risk of gastric atrophy among East Asians.

Authors:  Noel Pabalan; Neetu Singh; Maria Ruth Pineda; Hamdi Jarjanazi
Journal:  J Gastrointest Cancer       Date:  2014-09

Review 8.  Emerging blood-based biomarkers for detection of gastric cancer.

Authors:  Zane Kalniņa; Irēna Meistere; Ilze Kikuste; Ivars Tolmanis; Pawel Zayakin; Aija Linē
Journal:  World J Gastroenterol       Date:  2015-11-07       Impact factor: 5.742

9.  Association of polymorphism of PTPN 11 encoding SHP-2 with gastric atrophy but not gastric cancer in Helicobacter pylori seropositive Chinese population.

Authors:  Jing Jiang; Zhi-Fang Jia; Fei Kong; Mei-Shan Jin; Yin-Ping Wang; Suyan Tian; Jian Suo; Xueyuan Cao
Journal:  BMC Gastroenterol       Date:  2012-07-12       Impact factor: 3.067

10.  Polymorphisms of the DNA methyltransferase 1 associated with reduced risks of Helicobacter pylori infection and increased risks of gastric atrophy.

Authors:  Jing Jiang; Zhifang Jia; Donghui Cao; Mei-Shan Jin; Fei Kong; Jian Suo; Xueyuan Cao
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.